These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 24253833)
1. The effectiveness of primary care based risk stratification for targeted latent tuberculosis infection screening in recent immigrants to the UK: a retrospective cohort study. Panchal RK; Browne I; Monk P; Woltmann G; Haldar P Thorax; 2014 Apr; 69(4):354-62. PubMed ID: 24253833 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study. Berrocal-Almanza LC; Harris R; Lalor MK; Muzyamba MC; Were J; O'Connell AM; Mirza A; Kon OM; Lalvani A; Zenner D Lancet Infect Dis; 2019 Nov; 19(11):1191-1201. PubMed ID: 31471131 [TBL] [Abstract][Full Text] [Related]
3. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study. Winje BA; Grøneng GM; White RA; Akre P; Aavitsland P; Heldal E BMJ Open; 2019 Jan; 9(1):e023412. PubMed ID: 30782706 [TBL] [Abstract][Full Text] [Related]
4. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. Haukaas FS; Arnesen TM; Winje BA; Aas E Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772 [TBL] [Abstract][Full Text] [Related]
5. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Pareek M; Watson JP; Ormerod LP; Kon OM; Woltmann G; White PJ; Abubakar I; Lalvani A Lancet Infect Dis; 2011 Jun; 11(6):435-44. PubMed ID: 21514236 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345 [TBL] [Abstract][Full Text] [Related]
7. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study. Ronald LA; Campbell JR; Rose C; Balshaw R; Romanowski K; Roth DZ; Marra F; Schwartzman K; Cook VJ; Johnston JC Clin Infect Dis; 2019 Nov; 69(12):2101-2108. PubMed ID: 30856258 [TBL] [Abstract][Full Text] [Related]
8. Incidence of Tuberculosis Among Immigrants in Korea Who Participated in a Latent Tuberculosis Infection Screening Program. Lee YJ; Min J; Myong JP; Lee YH; Park YJ; Kim Y; Kim G; Park G; Lee SS; Park JS; Kim JS; Kim HW J Korean Med Sci; 2024 Jul; 39(28):e207. PubMed ID: 39048302 [TBL] [Abstract][Full Text] [Related]
9. Preventing tuberculosis in the foreign-born population of Canada: a mathematical modelling study. Varughese MB; Langlois-Klassen D; Long R; Li M Int J Tuberc Lung Dis; 2014 Apr; 18(4):405-12. PubMed ID: 24670694 [TBL] [Abstract][Full Text] [Related]
10. Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department. Nuzzo JB; Golub JE; Chaulk P; Shah M Am J Public Health; 2015 Jul; 105(7):1432-8. PubMed ID: 25602872 [TBL] [Abstract][Full Text] [Related]
11. Time for a preventative strategy for TB in the UK: further evidence for new entrant screening in primary care. Kon OM Thorax; 2014 Apr; 69(4):305-6. PubMed ID: 24385321 [No Abstract] [Full Text] [Related]
12. Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation. Zenner D; Loutet MG; Harris R; Wilson S; Ormerod LP Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751410 [TBL] [Abstract][Full Text] [Related]
13. Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study. Hargreaves S; Seedat F; Car J; Escombe R; Hasan S; Eliahoo J; Friedland JS BMC Infect Dis; 2014 Dec; 14():657. PubMed ID: 25466442 [TBL] [Abstract][Full Text] [Related]
14. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation. Spruijt I; Erkens C; Suurmond J; Huisman E; Koenders M; Kouw P; Toumanian S; Cobelens F; van den Hof S PLoS One; 2019; 14(7):e0219252. PubMed ID: 31260502 [TBL] [Abstract][Full Text] [Related]
15. Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Pareek M; Abubakar I; White PJ; Garnett GP; Lalvani A Eur Respir J; 2011 May; 37(5):1175-82. PubMed ID: 21071474 [TBL] [Abstract][Full Text] [Related]
16. Assessment of postarrival tuberculosis examinations among immigrants and refugees screened overseas. Gacek P; Sosa L; Lobato MN Conn Med; 2013; 77(6):325-30. PubMed ID: 23923248 [TBL] [Abstract][Full Text] [Related]
17. The outcome of a cohort of tuberculin-positive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001. Choudhury IW; West CR; Ormerod LP J Public Health (Oxf); 2014 Sep; 36(3):390-5. PubMed ID: 24277780 [TBL] [Abstract][Full Text] [Related]
18. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443 [TBL] [Abstract][Full Text] [Related]
19. Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting. Denholm JT; McBryde ES Aust N Z J Public Health; 2014 Feb; 38(1):78-82. PubMed ID: 24494951 [TBL] [Abstract][Full Text] [Related]
20. Persistent latent tuberculosis reactivation risk in United States immigrants. Walter ND; Painter J; Parker M; Lowenthal P; Flood J; Fu Y; Asis R; Reves R; Am J Respir Crit Care Med; 2014 Jan; 189(1):88-95. PubMed ID: 24308495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]